Literature DB >> 15119115

[Role of lipid peroxidation in non-alcoholic steatohepatitis].

Emil Fraenkel1, Ivica Lazúrová, János Fehér.   

Abstract

The liver steatosis is a frequent human disease. The most frequent cause of the process is the alcohol consumption. But it also may arise without significant alcohol abuse. This pathogenetic process is called non-alcoholic steatohepatitis (NASH), that is characterized by the same conditions like the alcoholic steatohepatitis. In the pathogenesis of the NASH various factors participate i.e. obesity, diabetes mellitus type II, hyperlipidaemia, pregnancy, variable chemotoxins, parenteral nutrition, jejunoileal bypass, chronic inflammatory diseases, protein deficient nutrition and inborn metabolic diseases. Pathobiochemically the process consists of oxidative stress and lipid peroxidation. This condition comes from the progressive accumulation of the free fatty acids in mitochondria and from the induction of cytochrome P450, CYP 2E1 isoform in hepatocytes and Kupffer cells. The free fatty acids and ketons can cause the induction of CYP 2E1 system, that is why diabetes mellitus and obesity are the two most important factors in the NASH pathogenesis. This article is concerned mainly in the explanation of NASH pathomechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15119115

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease.

Authors:  Xin Wang; Yuzhen Cao; Yunwei Fu; Guifang Guo; Xiuying Zhang
Journal:  Lipids Health Dis       Date:  2011-12-14       Impact factor: 3.876

Review 2.  Identification of Crucial Genetic Factors, Such as PPARγ, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry.

Authors:  Kerong Shi; Ranran Li; Zhongjin Xu; Qin Zhang
Journal:  Animals (Basel)       Date:  2020-04-07       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.